Balance Sheet

v3.25.1

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Mar. 31, 2024
Current assets:
Cash and cash equivalents	$ 713,971	$ 635,365
Accounts receivable	2,084	5,337
Prepaid expenses and other current assets	51,180	24,902
Income tax receivable	427	166
Total current assets	767,662	665,770
Operating lease right-of-use assets	98	133
Property and equipment, net	844	462
Other assets	7,618	0
Total assets	776,222	666,365
Current liabilities:
Accounts payable	17,656	7,155
Accrued expenses	50,748	41,300
Current portion of operating lease liabilities	98	138
Due to Roivant Sciences Ltd.	273	15
Total current liabilities	68,775	48,608
Total liabilities	68,775	48,608
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 170,111,593 shares issued and outstanding at March 31, 2025 and 500,000,000 shares authorized, 145,582,999 shares issued and outstanding at March 31, 2024	16	14
Additional paid-in capital	1,945,495	1,441,518
Accumulated other comprehensive income	1,459	1,908
Accumulated deficit	(1,239,523)	(825,683)
Total stockholders’ equity	707,447	617,757
Total liabilities and stockholders’ equity	776,222	666,365
Series A preferred stock
Stockholders’ equity:
Preferred stock	0	0
Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source